Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New immunosuppressants disclosed by Merck & Co.

Oct. 18, 1996

University of Texas discloses OMPs for immunotherapy

Oct. 18, 1996

Lyme disease vaccine claimed by University of Minnesota

Oct. 18, 1996

Magainin discloses LAP for microbial infections

Oct. 18, 1996

Washington University's MCP regulates complement activity

Oct. 18, 1996

University of North Carolina/Macronex research cytokine inhibitors

Oct. 18, 1996

Glaxo Wellcome claims antiviral agents with RNA virus specificity

Oct. 18, 1996

Pfizer discloses polycyclic ether antibiotics

Oct. 18, 1996

New antimigraine agents disclosed by Merck & Co.

Oct. 18, 1996

Merck & Co. reveals new series of tachykinin antagonists

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...